Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.
Clinical trial NCT05463679 · SUSPENDED
Trial details
- NCT number
- NCT05463679
- Sponsor
- Aytu BioPharma, Inc.
- Status
- SUSPENDED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2025-06-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.